Pharmaion Consultants offers brochure for "United states autoimmune disorders diagnostics market report" on the base of latest market trends & industry overviews...

1. India Adhesives Market
Forecast & Opportunities, 2020
United States Autoimmune Disorders Diagnostics
Market Opportunities, 2020
P h a r m a & H e a l t h c a r e C o n s u l t a n t s

2. 2
7
R e s e a r c h M e t h o d o l o g y
Primary Sources
•Identifying Key Opinion Leaders
•Questionnaire Design
•In-depth Interviews
•Coverage across Value Chain market
Market Estimation & Forecasting
Bottom-Up or Top-down approach for Market size estimation
Historical trend examination
Impact analysis of drivers and challenges to market growth
Statistical evaluation to develop the actual forecast
Data Validation, Analysis and Interpretation
Data validation through Primary & Secondary outreach, data analysis and
interpretation of key findings
Data Collection
Qualitative and Quantitative Research
United States Autoimmune
Disorders Diagnostics Market
Secondary Sources
•Government websites
•Company annual reports, white
papers, investor presentations and
financial reports
© Pharmaion
2015E 2016F 2017F 2018F 2019F 2020F
CAGR (2015E-2020F): XX%

3. 3
R e s e a r c h M e t h o d o l o g y
© Pharmaion
Baseline Methodology:
For the study of United States autoimmune disorders diagnostics market, Pharmaion has gathered information
through an exhaustive search of credible databases prudently evaluated all the collected information and presented
it in the most accurate and detailed manner.
Primary Research
Key Stakeholders:
 Product/Brand Managers
 Business Development
Managers
 Regional Mangers
 Regulatory Affairs Personnel
 Marketing & Sales Managers
 Head of Patient Support
Programme
Substantial data points for analysis,
interpretation and market size estimation
Data
Triangulation
(Data
validation
through cross
verification
from primary
& secondary
sources)
Qualitative and
quantitative data
from company
website, financial
reports, research
articles, designed
questionnaires
etc.
In-depth
interviews of key
stakeholders of
major companies
Secondary Research
Analysis of Data from credible
sources:
 Centers for Disease Control
and Prevention (CDC)
 WHO Reports
 American Autoimmune
Related Diseases Association
(AARDA)
 American College of
Rheumatology
 National Institute of Arthritis
and Musculoskeletal and Skin
Diseases

4. 4
R e s e a r c h M e t h o d o l o g y
United States Autoimmune Disorders Diagnostics Market - Market Size Estimation
 United States autoimmune disorders diagnostics market has been segmented into two segments:
systemic autoimmune disorders diagnostics and localized autoimmune disorders diagnostics.
 Further, the United States autoimmune disorders diagnostics market has been categorized into seven
sub-segments: Anti-Nuclear Antibody Test, Complete Blood Count Test, Erythrocyte Sedimentation Rate
(ESR), C-reactive protein, Comprehensive Metabolic Panel, Urinalysis and Others
 Anti-Nuclear antibody tests market have been further classified into three sub segments: ENA Panel,
Anti-dsDNA and Others (Anticentromere Antibody, Histone Antibody, Nucleolar Antibody, etc.).
Calculation of market size of
the US autoimmune
disorders diagnostics
market
Calculation of Sub-
segment market
size
Calculation
of regional
market
size
Top-downApproach
CAGR of forecast period obtained from the
primary and secondary outreach applied on
the given market
By Target Disease, Test & Technology Market
Size = Respective Market Share (From
Primary and Secondary Research) X Total
Market Value
Regional Market Size = Respective Market
Share (From Primary and Secondary
Research) X Total Market Value
© Pharmaion

5. Ta b l e o f C o n t e n t s
5
© Pharmaion
S No. Contents
1. Autoimmune Disorders Diagnostics Overview
2. Research Methodology
3. Analyst View
4. Disease Epidemiology
4. Global Autoimmune Disorders Diagnostics Market Overview
5. United States Autoimmune Disorders Diagnostics Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1.
By Target Disease (Systemic Autoimmune Disorders Diagnostics & Localized Autoimmune
Disorders Diagnostics)
5.2.2.
By Test (Urinalysis, Comprehensive Metabolic Panel, C-reactive Protein, Erythrocyte
Sedimentation Rate, Complete Blood Count, Anti-Nuclear Antibody Test & Others)
5.2.3.
By Technology (Enzyme Immunoassay, Multiplexed Immunoassays, Immunofluorescence &
Others)
5.2.4. By Region (South-West, West, North-East, Midwest, South-East)
6. United States Anti-Nuclear Antibody Test Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1.
By Type {Others (Anti-centromere Antibodies, Histone Antibody & Nucleolar Antibody), Anti-
dsDNA Test & ENA Panel}
7. Market Dynamics
7.1. Drivers
7.2. Challenges

6. Ta b l e o f C o n t e n t s
S No. Contents
8. Market Trends & Developments
8.1. Increasing Use of Biomarkers
8.2. Lab automation
8.3. Lab-on- Chip Device
8.4. Portable Diagnostic Equipment
8.5. Partnership with Physician and Diagnostic Laboratories
9. Policy & Regulatory Landscape
10. United States Economic Profile
11. Competitive Landscape
11.1. Competition Benchmarking (Market Attractiveness)
11.2. Company Profiles
11.2.1. Bio-Rad Laboratories, Inc.
11.2.2. Roche Diagnostics Corporation
11.2.3. Abbott Laboratories
11.2.4. Danaher Corporation
11.2.5. Siemens Healthcare Diagnostics, Inc.
11.2.6. Biomeriux Clinical Diagnostics
11.2.7. Immco Diagnostics
11.2.8. Beckton Dickson
11.2.9. Alere Inc.
11.2.10. Inova Diagnostics, Inc.
12. Strategic Recommendations
13. About Us & Disclaimer 3
© Pharmaion

7. I n d u s t r y B r i e f
7
© Pharmaion
United States Autoimmune Disorders Diagnostics Market to Surpass US$ 6 Billion by 2020
Growing prevalence of autoimmune disorders and various ongoing technological advancements to drive the
United States autoimmune disorders diagnostics market
According to recently published Pharmaion report, “United States Autoimmune Disorders Diagnostics
Market Opportunities, 2020”,the autoimmune disorders diagnostics market in the United States is
anticipated to cross US$ 6 billion by 2020. Some of the major autoimmune diseases include Rheumatoid
Arthritis, Type 1 Diabetes, Multiple Sclerosis, Systemic Lupus Erythematosus (SLE), Inflammatory Bowel
Disease (IBD), Psoriasis and Autoimmune Thyroiditis, etc. According to American Autoimmune Related
Diseases Association (AARDA), 50 million Americans are suffering from more than 100 types of
autoimmune disorders, and 75-85% of the total autoimmune disorders patients in the country are women.
Growth in the market is anticipated on account of growing disease burden of various autoimmune
disorders, increasing healthcare expenditure and various ongoing technological advancements. Moreover,
increasing automation in laboratories leading to precise and faster diagnosis is forecast to further fuel the
market of autoimmune disorders diagnostics in the United States during 2015 - 2020.On the basis of target
disease, the market is broadly segmented into two categories, namely, systemic autoimmune disorders
diagnostics and localized autoimmune disorders diagnostics. Among these two categories, systemic
autoimmune disorders diagnostics segment dominated the United States autoimmune disorders diagnostics
market in 2014, and the segment is anticipated to continue its dominance through 2020 on account of
increasing ongoing research activities that are focused on developing tests and technologies that would
precisely detect the abnormalities in organ functioning and deliver faster diagnosis.
“With growing adoption of biomarkers, Lab-on-Chip devices and portable diagnostic equipment, the market
for autoimmune disorders diagnostics in the United States is anticipated to grow over the next five years.
Moreover, National Institute of Allergy and Infectious Diseases (NIAID) is organizing a clinical research
program - Autoimmunity Centre of Excellence (ACEs) for effective diagnosis and treatment of autoimmune
diseases by expanding collaborative research across medical specialties, scientific disciplines, and basic &
clinical scientists.", said Mr. Karan Chechi, Research Director of Pharmaion, a research based global
pharmaceutical and healthcare consulting firm.

8. Autoimmune disorders occur when a person’s immune system attacks his/her own body; and for detecting
these disorders and prescribing required treatments, various laboratory tests are performed. On the basis of
disorder type, autoimmune disorders diagnostics market in the US has been segmented into two categories,
namely, systemic autoimmune disorders diagnostics and localized autoimmune disorders diagnostics.
P r o d u c t O v e r v i e w
Autoimmune Disorders Diagnostics Market
Systemic Autoimmune
Disorders Diagnostics
Localised Autoimmune
Disorders Diagnostics
Systemic Autoimmune Disorders Diagnostics: They are non-organ specific disease which affects multiple
organs and tissues of the body is known as systematic autoimmune disorder. It broadly involves the diagnosis
of diseases, such as Systemic Lupus Erythematosus (SLE), Rheumatoid Arthritis, Ankylosing Spondylitis, etc.,
which are mainly diagnosed by rheumatologists and clinical immunologists.
Localised Autoimmune Disorders Diagnostics: They are organ specific disease which effects single organ
or tissue of the body and are diagnosed mainly by rheumatologists, endocrinologists and neurologists. It
mainly involves the diagnosis of diseases like Multiple Sclerosis, Inflammatory Bowel Disease (IBD), Type 1
Diabetes, Thyroid, etc.
6
© Pharmaion

9. 9
Autoimmune
Disorder
Annual Cost* per
Patient (USD)
X X
X X
X X
X X
X X
50
100
150
Diabetes Type 1 Systemic Lupus
Erthymatosus (SLE)
Rheumatoid Arthritis
United States Autoimmune Disorders Prevalence per
100,000 Population, 2013
United States Average Annual Cost of Diagnosis and
Treatment of Autoimmune Disorders, 2014
Sample Data - Snapshot
© Pharmaion
1 2 3 4 5 7 8 9 10 11 12
2010 2011 2012 2013 2014 2015E2016F2017F2018F2019F2020F
United States Autoimmune Disorders Diagnostics
Market Size, By Value, 2010-2020F (USD Billion)
3.00% 3.0… 3.02% 3.03% 3.04% 3.05% 3.06% 3.07% 3.08% 3.09% 3.10%
6.00% 6.01% 6.02% 6.03% 6.04% 6.05% 6.06% 6.07% 6.08% 6.09% 6.10%
8.00% 8.01% 8.02% 8.03% 8.04% 8.05% 8.06% 8.07% 8.08% 8.09% 8.10%
9.00% 9.01% 9.02% 9.03% 9.04% 9.05% 9.06% 9.07% 9.08% 9.09% 9.10%
14.00% 14.01% 14.02% 14.03% 14.04% 14.05% 14.06% 14.07% 14.08% 14.09% 14.10%
17.00% 17.01% 17.02% 17.03% 17.04% 17.05% 17.06% 17.07% 17.08% 17.09% 17.10%
35.00% 35.01% 35.02% 35.03% 35.04% 35.05% 35.06% 35.07% 35.08% 35.09% 35.10%
2010 2011 2012 2013 2014 2015E 2016F 2017F 2018F 2019F 2020F
Anti-Nuclear Antibody Test Complete Blood Count (CBC)
Erythrocyte Sedimentation Rate (ESR) C-reactive Protein
United States Autoimmune Disorders Diagnostics Market Share, By Test,
By Value, 2010-2020F
Midwest
West
North-
East
South-
West
South-
East
2014: X%
2020F: X%
2014: X%
2020F: X%
2014: X%
2020F: X%
2014: X%
2020F: X%
2014: X%
2020F: X%
United States Autoimmune Disorders Diagnosis Market
Share, By Region, By Value, 2014 & 2020F
Clinical
Diagnosti
cs,
50.00%
Life
Science,
50.00%
Other
Countries,
50.00%
Unites
States,
50.00%
SEGMENTAL REVENUE BREAK UP, 2014
By Business Segments By Geography

10. ©
10
R e p o r t O r d e r i n g
License Type Price
Single User License $3000
Single User License Print $3500
Enterprise License $5000
To View Sample OR Purchase Report
Report Price
Report Name: United States Autoimmune Disorders Diagnostics Market
Opportunities, 2020

11. A b o u t U s & D i s c l a i m e r
11
NORTH AMERICA
Pharmaion Consultants LLC
708 3RD Avenue, 6th Floor, New York, NY,
United State, 10017
sales@pharmaion.com
+1 646 360 1656
www.pharmaion.com
About Us :
Pharmaion is a research based management consulting firm focused exclusively on Healthcare & Pharmaceutical industry.
Pharmaion’s core values are value, integrity and insight. Led by a team of dynamic industry experts, Pharmaion provides its customers
with high value market research and advisory services that helps them identify new market opportunities, growth engines and
innovative ways to capture the market share. As a result, Pharmaion’s clients lead rather than follow market trends. Not bound by
legacy, Pharmaion’s cutting-edge research model leverages its decades of research knowledge and an increased use of technology as
engines of innovation to deliver unique research value. Provided as an alternative to traditional market research, Pharmaion’s reports
do not just deliver data and knowledge rather highlights the insights in a more usable and interactive format for its clients.
Pharmaion is committed to assisting customers worldwide with their unique market research needs by providing them with
comprehensive, value-added solutions and professional market intelligence services. Pharmaion employs the industry’s best-trained
industry Analysts and Consultants, which advises and assists customers in meeting their full service market research and consulting
requirements.
Related Reports
India Stem Cell Market Opportunities, 2020
Global Tissue Engineered Medical Devices Market Opportunities, 2020
Global Cervical Cancer Vaccine Market Opportunities, 2020
Disclaimer :
The contents of this report are based on information generally available to the public from sources believed to be reliable. No representation is made
that it is timely, accurate or complete. Pharmaion Consultants has taken due care and caution in compilation of data as this has been obtained from
various sources including which it considers reliable and first hand. However, Pharmaion Consultants does not guarantee the accuracy, adequacy or
completeness of any information and it is not responsible for any errors or omissions or for the results obtained from the use of such information and
especially states that it has no financial liability whatsoever to the subscribers / users of this report. The information herein, together with all estimates
and forecasts, can change without notice. All the figures provided in this document are indicative of relative market size and are strictly for client’s
internal consumption. Usage of the same for purpose other than internal will require prior approval of Pharmaion Consultants.
ASIA PACIFIC
Pharmaion Consultants Pvt. Ltd.
A – 51, Sector 57, Noida, National Capital Region,
India - 201301
sales@pharmaion.com
+91 - 120 - 452 3900
www.pharmaion.com © Pharmaion